During the past decade, MCB Clinical Research Centers, LLC conducted 39 clinical trials. In the 10-year time frame, 39 clinical trials started and 32 clinical trials were completed, i.e. on average, 82.1% percent of trials that started reached the finish line to date. In the past 5 years, 8 clinical trials started and 20 clinical trials were completed. i.e. 250% of trials that started reached the finish line.

Out of the total clinical trials conducted in "MCB Clinical Research Centers, LLC" #1 sponsor was "Sunovion" with 7 trials, followed by "Shire" with 6 trials sponsored, "Supernus Pharmaceuticals, Inc." with 4 trials sponsored, "Hoffmann-La Roche" with 3 trials sponsored and "Naurex, Inc, an affiliate of Allergan plc" with 3 trials sponsored. Other sponsors include 20 different institutions and companies that sponsored additional 24 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "MCB Clinical Research Centers, LLC" #1 collaborator was "Sucampo AG" with 1 trials as a collaborator, "Takeda" with 1 trials as a collaborator and "University of Michigan" with 1 trials as a collaborator. Other collaborators include -3 different institutions and companies that were collaborators in the rest 3 trials.

According to Clinical.Site data, the most researched conditions in "MCB Clinical Research Centers, LLC" are "Major Depressive Disorder" (8 trials), "Depressive Disorder, Major" (5 trials), "Attention Deficit Hyperactivity Disorder" (4 trials), "Attention Deficit Hyperactivity Disorder (ADHD)" (4 trials) and "Adult Attention Deficit Hyperactivity Disorder" (3 trials). Many other conditions were trialed in "MCB Clinical Research Centers, LLC" in a lesser frequency.

Most popular intervention types in "MCB Clinical Research Centers, LLC" are "Drug" (47 trials), "Other" (3 trials) and "Genetic" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (27 trials), "Dasotraline" (5 trials), "Rapastinel" (3 trials), "Aticaprant" (2 trials) and "Lisdexamfetamine dimesylate" (2 trials). Other intervention names were less common.

The vast majority of trials in "MCB Clinical Research Centers, LLC" are 47 trials for "All" genders and 1 trials for "Female" genders.

Currently, there are NaN active trials in "MCB Clinical Research Centers, LLC". undefined are not yet recruiting, 4 are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 33 completed trials in MCB Clinical Research Centers, LLC, undefined suspended trials, and 9 terminated clinical trials to date.

Out of the total trials that were conducted in MCB Clinical Research Centers, LLC, 1 "Phase 1" clinical trials were conducted, 8 "Phase 2" clinical trials and 34 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 5 trials, and there were also 1 trials that are defined as “Not Applicable".